Funding for this research was provided by:
Text and Data Mining valid from 2018-03-15
Received: 20 October 2017
Accepted: 29 December 2017
First Online: 15 March 2018
Ethics approval and consent to participate
: The study was conducted in agreement with the Declaration of Helsinki. The protocol was approved by the Institutional Review Board (IRB) of Jichi Medical University, and all patients gave their written informed consent before undergoing any study procedure.
: Not applicable.
: T.O. has received research funding from Bayer AG. K.K. has received honoraria from Takeda Pharmaceutical Company Limited., Daiichi Sankyo Co., Ltd., and Omron Healthcare Co., Ltd., as well as research grants from Teijin Pharma Limited, Omron Healthcare Co., Ltd., Fukuda Denshi, Bayer Yakuhin Ltd., A&D Co., Ltd., Daiichi Sankyo Co., Ltd., Mochida Pharmaceutical Co., Ltd., EA Pharma, Otsuka Pharmaceutical Co., Ltd., Boehringer Ingelheim Japan Inc., Mitsubishi Tanabe Pharma Corporation, and Medtronic Japan Co., Ltd. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.